PHARMACEUTICALLY ACTIVE NEW LEUROSINE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF

Multiple myeloma in human patients is treated by administering N-formylleurosine or its sulfate salt.

Saved in:
Bibliographic Details
Main Authors DESZERI E, SZASZ K, BITTNER E, RELLE Z, KELLNER B, JOVANOCICS K, NEMETH L, ELES J
Format Patent
LanguageEnglish
Published 26.02.1975
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Multiple myeloma in human patients is treated by administering N-formylleurosine or its sulfate salt.
Bibliography:Application Number: ZA19740001015